Cargando…

The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation

The management of recurrent hepatocellular carcinoma untreatable with surgical options is based on systemic therapy with sorafenib. Due to the high rates of adverse events connected to the therapy with sorafenib, metronomic capecitabine seems a promising strategy for these patients. We analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravaioli, Matteo, Cucchetti, Alessandro, Pinna, Antonio Daniele, De Pace, Vanessa, Neri, Flavia, Barbera, Maria Aurelia, Maroni, Lorenzo, Frega, Giorgio, Palloni, Andrea, De Lorenzo, Stefania, Ripoli, Maria Cristina, Pantaleo, Maria Abbondanza, Cescon, Matteo, Del Gaudio, Massimo, Brandi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595852/ https://www.ncbi.nlm.nih.gov/pubmed/28900245 http://dx.doi.org/10.1038/s41598-017-11810-z

Ejemplares similares

Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
por: Brandi, Giovanni, et al.
Publicado: (2018)

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept
por: De Lorenzo, Stefania, et al.
Publicado: (2018)

Surgical management of hepatocellular carcinoma—Western versus Eastern attitude
por: Neri, Flavia, et al.
Publicado: (2019)

In Reply
por: Brandi, Giovanni, et al.
Publicado: (2016)

Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?
por: Brandi, Giovanni, et al.
Publicado: (2020)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Challenging liver lesions in noncirrhotic patients: Report of three cases
por: Franceschini, Tania, et al.
Publicado: (2019)

Combined Kidney-Liver, Heart-Liver, and Kidney-Pancreas Transplantations from a Single Deceased Donor
por: Ravaioli, Matteo, et al.
Publicado: (2012)

Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)

Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
por: Marinelli, Sara, et al.
Publicado: (2013)

Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria
por: Ravaioli, Matteo, et al.
Publicado: (2019)

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
por: Al-Sukhun, Sana, et al.
Publicado: (2023)

Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial
por: Ravaioli, Matteo, et al.
Publicado: (2022)

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
por: Jung, Yun Hwa, et al.
Publicado: (2017)

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2014)

Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis
por: Wang, Hao, et al.
Publicado: (2023)

Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)

Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study
por: Vasuri, Francesco, et al.
Publicado: (2023)

Liver Transplantation in Patients with Portal Vein Thrombosis: Revisiting Outcomes According to Surgical Techniques
por: Pinelli, Domenico, et al.
Publicado: (2023)

Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma
por: Cescon, Matteo, et al.
Publicado: (2010)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys
por: Ravaioli, Matteo, et al.
Publicado: (2017)

Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas
por: Vasuri, Francesco, et al.
Publicado: (2018)

Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature
por: Gatto, Lidia, et al.
Publicado: (2020)

Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial
por: Ravaioli, Matteo, et al.
Publicado: (2020)

Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial
por: Ravaioli, Matteo, et al.
Publicado: (2020)

Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study
por: Serenari, Matteo, et al.
Publicado: (2021)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
por: Casadei Gardini, Andrea, et al.
Publicado: (2017)

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
por: Berruti, Alfredo, et al.
Publicado: (2014)

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study
por: Pietrantonio, Filippo, et al.
Publicado: (2016)

Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
por: Geng, Rui, et al.
Publicado: (2020)

Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations
por: Brandi, Giovanni, et al.
Publicado: (2012)

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial
por: Ravaioli, Matteo, et al.
Publicado: (2020)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Two-stage hepatectomy with radioembolization for bilateral colorectal liver metastases: A case report
por: Serenari, Matteo, et al.
Publicado: (2021)

Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review
por: Maur, Michela, et al.
Publicado: (2017)

Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients
por: Siniscalchi, Antonio, et al.
Publicado: (2020)

From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
por: Vernmark, Karolina, et al.
Publicado: (2015)

The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study
por: Serenari, Matteo, et al.
Publicado: (2020)

Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy
por: Qiao, Guoliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bvn35bdi4t7ku9o4dvlgq4cvdu